Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder

BACKGROUND: This randomized, placebo-controlled, crossover trial examined the antidepressant efficacy of the muscarinic antagonist scopolamine in major depressive disorder subjects with more severe and refractory forms of major depressive disorder relative to previous reports. METHODS: Participants...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Neuropsychopharmacol
Main Authors: Park, Lawrence, Furey, Maura, Nugent, Allison C, Farmer, Cristan, Ellis, Jessica, Szczepanik, Joanna, Lener, Marc S, Zarate, Carlos A
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Regular Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6313153/
https://ncbi.nlm.nih.gov/pubmed/30184133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyy051
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados